中华超声影像学杂志
中華超聲影像學雜誌
중화초성영상학잡지
Chinese Journal of Ultrasonography
2015年
8期
701-704
,共4页
腔内超声检查%前列腺增生%聚桂醇%硬化疗法
腔內超聲檢查%前列腺增生%聚桂醇%硬化療法
강내초성검사%전렬선증생%취계순%경화요법
Endosonography%Prostatic hyperplasia%Lauromacrogol%Sclerotherapy
目的：观察经直肠超声引导注射聚桂醇治疗合并下尿路梗阻症状的老年良性前列腺增生的疗效。方法直肠超声引导下对42例合并下尿路梗阻症状的老年良性前列腺增生患者行前列腺内注射聚桂醇硬化治疗,治疗后1、3、6、12个月随访,观察治疗前后前列腺内腺体积变化、国际前列腺疾患排尿症状评分(IPSS)、残余尿量(PVR)及最大尿流率(Qmax),观察治疗前后超声造影表现,分析其并发症。结果治疗前患者的前列腺内腺体积、IPSS、PVR 分别为(57.3±17.7)ml、(28.3±5.2)分、(143.8±82.5)ml,治疗后12个月分别减小到(44.8±6.1)ml、(8.8±1.4)分、(28.9±9.5)ml,与治疗前比较差异均具有统计学意义(P <0.05),Qmax 由治疗前(5.9±3.2)ml/s 提高到(14.9±3.1)ml/s(P <0.05),超声造影显示前列腺内腺出现充盈缺失,未出现明显并发症。结论经直肠超声引导下注射聚桂醇治疗前列腺增生具有微创、安全、有效、经济的特点,适用于不能或不愿接受手术治疗的老年患者。
目的：觀察經直腸超聲引導註射聚桂醇治療閤併下尿路梗阻癥狀的老年良性前列腺增生的療效。方法直腸超聲引導下對42例閤併下尿路梗阻癥狀的老年良性前列腺增生患者行前列腺內註射聚桂醇硬化治療,治療後1、3、6、12箇月隨訪,觀察治療前後前列腺內腺體積變化、國際前列腺疾患排尿癥狀評分(IPSS)、殘餘尿量(PVR)及最大尿流率(Qmax),觀察治療前後超聲造影錶現,分析其併髮癥。結果治療前患者的前列腺內腺體積、IPSS、PVR 分彆為(57.3±17.7)ml、(28.3±5.2)分、(143.8±82.5)ml,治療後12箇月分彆減小到(44.8±6.1)ml、(8.8±1.4)分、(28.9±9.5)ml,與治療前比較差異均具有統計學意義(P <0.05),Qmax 由治療前(5.9±3.2)ml/s 提高到(14.9±3.1)ml/s(P <0.05),超聲造影顯示前列腺內腺齣現充盈缺失,未齣現明顯併髮癥。結論經直腸超聲引導下註射聚桂醇治療前列腺增生具有微創、安全、有效、經濟的特點,適用于不能或不願接受手術治療的老年患者。
목적：관찰경직장초성인도주사취계순치료합병하뇨로경조증상적노년량성전렬선증생적료효。방법직장초성인도하대42례합병하뇨로경조증상적노년량성전렬선증생환자행전렬선내주사취계순경화치료,치료후1、3、6、12개월수방,관찰치료전후전렬선내선체적변화、국제전렬선질환배뇨증상평분(IPSS)、잔여뇨량(PVR)급최대뇨류솔(Qmax),관찰치료전후초성조영표현,분석기병발증。결과치료전환자적전렬선내선체적、IPSS、PVR 분별위(57.3±17.7)ml、(28.3±5.2)분、(143.8±82.5)ml,치료후12개월분별감소도(44.8±6.1)ml、(8.8±1.4)분、(28.9±9.5)ml,여치료전비교차이균구유통계학의의(P <0.05),Qmax 유치료전(5.9±3.2)ml/s 제고도(14.9±3.1)ml/s(P <0.05),초성조영현시전렬선내선출현충영결실,미출현명현병발증。결론경직장초성인도하주사취계순치료전렬선증생구유미창、안전、유효、경제적특점,괄용우불능혹불원접수수술치료적노년환자。
Objective To observe the preliminary curative effect of transrectal ultrasound-guided lauromacrogol injection for treating benign prostate hyperplasia in elderly patients.Methods Forty-two patients with benign prostate hyperplasia combined with lower urinary tract symptonms received transrectal ultrasound-guided lauromacrogol injection.Then they were followed up after 3,6,12 months respectively. Prostate volume changes before and after treatment,international prostate symptom score(IPSS),postvoid residual volume (PRV ),maximum urinary flow rate (Qmax ) and features of contrast-enhanced ultrasonography before and after treatment were observed.Complications were analyzed.Results Before treatment,prostate volume,IPSS,PVR of patients were (57.3±1 7.7)ml,(28.3 ±5.2)points,(143.8±82.5) ml respectively,12 months after treatment,they reduced to (44.8 ±6.1 )ml,(8.8 ± 1 .4)points,(28.9 ±9.5 ) ml,there were statistical diffrences between before and after treatment(P <0.05 ).Qmax increased from (5.9±3.2)ml/s to (14.9 ±3.1 )ml/s (P <0.05).Contrast-enhanced ultrasonography showed filling defect sign in prostatic inner gland.No serve complications occurred.Conclusions Transrectal ultrasound-guided lauromacrogol injection for treating benign prostate hyperplasia has the characteristics of minimally invasive,safe,effective and economical.It applies to elderly patients who are unable or unwilling to have surgery.
